The definitive mechanism behind reducing cardiomyopathy via ARBs, ACEIs, and/or BBs in DMD patients is not completely established, but reduced aldosterone signaling through ACE inhibition could prevent fibrotic tissue development, as previous use of aldosterone-specific blockers has shown benefit in cases of heart failure[39-42]. This evidence concerns the gene ACE and Duchenne muscular dystrophy.